Acadian Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,145
Closed -$860K 1828
2024
Q4
$860K Sell
2,145
-3,598
-63% -$1.44M ﹤0.01% 950
2024
Q3
$2.66M Sell
5,743
-15,348
-73% -$7.12M 0.01% 666
2024
Q2
$9.88M Buy
21,091
+3,257
+18% +$1.52M 0.03% 354
2024
Q1
$7.44M Sell
17,834
-697
-4% -$291K 0.03% 370
2023
Q4
$7.53M Sell
18,531
-5,725
-24% -$2.33M 0.03% 349
2023
Q3
$8.43M Buy
24,256
+432
+2% +$150K 0.04% 321
2023
Q2
$8.37M Sell
23,824
-13,296
-36% -$4.67M 0.03% 331
2023
Q1
$11.7M Sell
37,120
-120,321
-76% -$37.9M 0.05% 282
2022
Q4
$45.4M Buy
157,441
+35,552
+29% +$10.3M 0.22% 123
2022
Q3
$35.3M Buy
121,889
+103,314
+556% +$29.9M 0.19% 130
2022
Q2
$5.23M Sell
18,575
-5,882
-24% -$1.66M 0.03% 402
2022
Q1
$6.38M Buy
24,457
+15,380
+169% +$4.01M 0.03% 409
2021
Q4
$1.99M Sell
9,077
-328,874
-97% -$72.1M 0.01% 657
2021
Q3
$61.3M Buy
337,951
+88,374
+35% +$16M 0.23% 106
2021
Q2
$50.3M Buy
249,577
+199,401
+397% +$40.2M 0.19% 129
2021
Q1
$10.8M Buy
50,176
+4,400
+10% +$946K 0.04% 319
2020
Q4
$10.8M Buy
45,776
+24,272
+113% +$5.74M 0.04% 324
2020
Q3
$5.85M Buy
21,504
+4,028
+23% +$1.1M 0.02% 410
2020
Q2
$5.08M Buy
17,476
+12,505
+252% +$3.63M 0.02% 483
2020
Q1
$1.18M Buy
4,971
+3,784
+319% +$900K 0.01% 742
2019
Q4
$260K Buy
+1,187
New +$260K ﹤0.01% 1234
2019
Q2
Sell
-854
Closed -$157K 2057
2019
Q1
$157K Sell
854
-17,962
-95% -$3.3M ﹤0.01% 1415
2018
Q4
$3.12M Sell
18,816
-4,716
-20% -$781K 0.02% 473
2018
Q3
$4.54M Buy
23,532
+18,926
+411% +$3.65M 0.02% 395
2018
Q2
$784K Sell
4,606
-162
-3% -$27.6K ﹤0.01% 793
2018
Q1
$777K Sell
4,768
-15,022
-76% -$2.45M ﹤0.01% 768
2017
Q4
$2.97M Sell
19,790
-178,403
-90% -$26.7M 0.01% 477
2017
Q3
$30.1M Sell
198,193
-22,756
-10% -$3.46M 0.13% 152
2017
Q2
$28.5M Buy
+220,949
New +$28.5M 0.13% 159
2015
Q1
Sell
-1,510
Closed -$179K 1476
2014
Q4
$179K Buy
+1,510
New +$179K ﹤0.01% 903